Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • give logo Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Dates and Deadlines
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Guidelines for Participating in SfN Events
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2024 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Attend
      • Read
      • Watch
      • Listen
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Diversity Initiatives
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
31 - 40 of 890 results
  • Abstract
    Acute effects of legal market high potency THC-dominant vs. CBD-dominant cannabis concentrates: objective and subjective intoxication outcomes
    As the market for cannabis concentrate products continues to grow, the lack of research regarding the combined and differential effects of concentrated forms of the two most prominent cannabinoids, THC and CBD, becomes more glaring. The present study an...
    Nov 11, 2021
  • Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity | Journal of Neuroscience
    Excitotoxicity is a paradigm used to explain the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. Here, we show in a longitudinal magnetic resonance imaging study that Δ9-tetrahydrocannabinol (Δ9-THC), the main active compound in marijuana, reduces neuronal injury in neonatal rats injected intracerebrally with the Na+/K+-ATPase inhibitor ouabain to elicit excitotoxicity. In the acute phase Δ9-THC reduced the volume of cytotoxic edema by 22%. After 7 d, 36% less neuronal damage was observed in treated rats compared with control animals. Coadministration of the CB1 cannabinoid receptor antagonist SR141716 prevented the neuroprotective actions of Δ9-THC, indicating that Δ9-THC afforded protection to neurons via the CB1 receptor. In Δ9-THC-treated rats the volume of astrogliotic tissue was 36% smaller. The CB1 receptor antagonist did not block this effect. These results provide evidence that the cannabinoid system can serve to protect the brain against neu...
    Sep 1, 2001 M. van der Stelt
  • Abstract
    Cannabidiol mediated regulation of alcohol consumption
    The aim of this study was to evaluate the effects of cannabidiol (CBD) in alcohol reinforcement, motivation and relapse in C57BL/6J mice. To this purpose, the effects of CBD (60 mg/kg i.p.) and ethanol on rectal temperature (3 g/kg p.o.), ethanol-handli...
    Nov 12, 2016
  • Abstract
    Cannabidiol a drug lacking reinforcing activity
    Cannabidiol, one of the main compounds present in the plant Cannabis sativa, has recently emerged as a potential drug for the treatment of different psychiatric disorders, based on its anxiolytic, antidepressant and antipsychotic properties. However, so...
    Nov 12, 2016
  • Abstract
    Unable to Attend-Behavioral and molecular effects of peripubertal cannabidiol treatment on perinatal delta-9-tetrahydrocannabinol exposed rats
    Epidemiological and clinical studies suggest that a neurodevelopmental dysfunction could be one of the main exploratory hypotheses of schizophrenia (SCZ), which symptoms lead to severe personal and social dysfunctions. A variety of animal and human stud...
    Nov 7, 2018
  • Abstract
    Cannabidiol (CBD) interrupts a novel positive feedback loop involving LPI-GPR55 signaling to restore excitatory-to-inhibitory coordination
    Recent clinical trials suggest that cannabidiol (CBD), a non-psychoactive component of cannabis, can reduce seizure frequency in several forms of pediatric epilepsy. While the exact anti-seizure mechanism of CBD is unclear, one leading hypothesis predic...
    Nov 12, 2017
  • Abstract
    An objective method to assess the anti-migraine properties of delta-9-tetrahydrocannabinol (THC) in the female rat
    Migraine affects 15% of the world’s population, yet treatment options are either ineffective or accompanied by adverse effects such as medication overuse headache. Anecdotal and clinical evidence suggest that cannabinoids present in marijuana have anti-...
    Nov 13, 2016
  • Abstract
    A comparison between delta-9-tetrahydrocannabinol and a Jamaican marijuana tea extract in an animal model of addiction
    Marijuana is the most widely used illicit drug world-wide because of its psychoactive compound, ∆9-tetrahydrocannabinol (THC). The plant, Cannabis sativa, however contains a myriad of other non-psychoactive cannabinoids. In Jamaica, it is smoked, drank ...
    Nov 12, 2016
  • Abstract
    Altered regional blood volume in chronic marijuana smokers.
    Marijuana remains the most commonly abused illicit substance in the United States, however, the effects of cannabis on cerebral blood volume (CBV) have not been fully examined. Given reported changes in frontal BOLD activation in marijuana smokers the objective of the present study was to examine both cerebral (frontal and temporal areas) and cerebellar blood volume during a period of supervised abstinence. Dynamic susceptibility contrast (DSC) MRI data were collected on eleven current, long-term marijuana users (MJ) between 6 hours and 36 hours after the subject's last reported cannabis use. Resting state CBV images were also acquired in 11 healthy comparison subjects (NCs). Data were acquired in the axial plane following a bolus of gadolinium contrast agent with a 1.5-Tesla GE Signa scanner. MJ smokers demonstrated significantly increased blood volumes in the left temporal area (p= 0.018) and in the cerebellum (p= 0.023) relative to control subjects. A regression analysis revealed that age was not signif...
    Nov 14, 2005
  • Abstract
    Estradiol enhances antinociceptive and motoric effects of THC.
    We have previously shown that cannabinoid agonists, including delta-9-tetrahydrocannabinol (THC), are more potent and in some cases more efficacious in female than in male rats, in terms of their antinociceptive and motoric effects (Tseng & Craft, Eur J Pharmacol 430:41, 2001). In the present study, we manipulated gonadal steroid hormone state in adulthood, to determine to what extent activational effects of gonadal steroids are responsible for sex differences in sensitivity to the behavioral effects of THC. Adult Sprague-Dawley rats were gonadectomized; half of the females were implanted s.c. with estradiol (1-mm capsule/rat), and half of the males were implanted with testosterone (10-mm capsule/100 g body weight), and the rest of the rats were implanted with blank capsules of comparable length and number. Three weeks later, rats were injected with THC (5 mg/kg i.p.) or vehicle (1:1:18 emulphor:ethanol:saline) and tested for antinociception (tail withdrawal and paw pressure tests) and motor behaviors (hor...
    Nov 13, 2005
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Featured

  • Watch: The Inspiration Behind the Neuroscience 2025 Logo
  • Upcoming Webinar: JNeurosci Town Hall
  • Find a Roommate for Neuroscience 2025 in the Roommate Matching Forum
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience